Exhibit 1
Joint Filing Agreement
AGREEMENT dated as of September 24, 2015, by and among WPP Luxembourg Gamma Three S.à r.l. and WPP plc (collectively, the “Parties”).
Each of the Parties hereto represents to the other Parties that it is eligible to use Schedule 13D to report its beneficial interest in the common stock of OptimizeRx Corporation (“Schedule 13D”) and it will file the Schedule 13D on behalf of itself.
Each of the Parties agrees to be responsible for the timely filing of the Schedule 13D and any and all amendments thereto and for the completeness and accuracy of the information concerning itself contained in the Schedule 13D, and the other Parties to the extent it knows or has reason to believe that any information about the other Parties is inaccurate.
| WPP LUXEMBOURG GAMMA THREE S.À R.L. | ||||||
| By: | /s/ Anne Ehrismann | |||||
| Name: Anne Ehrismann | ||||||
| Title: Manager | ||||||
| By: | /s/ Thierry Lenders | |||||
| Name: Thierry Lenders | ||||||
| Title: Manager | ||||||
| WPP PLC | ||||||
| By: | /s/ Paul W.G. Richardson | |||||
| Name: Paul W.G. Richardson | ||||||
| Title: Chief Financial Officer | ||||||
